Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nociceptive threshold evaluation in opioid-dependent patients receiving methadone or high-dose buprenorphine substitution
2007-005291-14Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methadone and buprenorphine in opioid use disorder (OUD) (3 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Nov 2007; status: active.
02
Drugs
methadonebuprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2007-005291-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005291-14.